By Devika Patel
Knoxville, Tenn., Aug. 3 - Mymetics Corp. has raised $1.65 million in a private placement of stock, according to a form 8-K filed with the Securities and Exchange Commission Friday.
The company sold 5.5 million restricted shares to Hazuna Ltd. at $0.30 per share.
Mymetics is a Nyon, Switzerland-based biotechnology research and development company focused on developing vaccines and therapies for retroviruses, including HIV.
Issuer: | Mymetics Corp.
|
Issue: | Stock
|
Amount: | $1.65 million
|
Shares: | 5.5 million
|
Price: | $0.30
|
Warrants: | No
|
Investor: | Hazuna Ltd.
|
Stock symbol: | OTCBB: MYMX
|
Stock price: | $0.13 at close Aug. 3
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.